90TEN picked up the Communiqué Communications Consultancy of the Year at last night’s 2019 Communiqué Awards in London, seeing off competition from GCI, Hanover Health, In
Novo Nordisk's anti-TFPI antibody concizumab has been backed for approval in the EU as a once-daily drug to prevent bleeding episodes in people with haemophilia.